logo

For the Inventor, By the Inventor

Mahtomedi, MN, United States of America

Stephen L Crooks

This inventor holds 40 USPTO granted patents, primarily in Imidazoquinoline Chemistry. Top assignees: 3M Innovative Properties Company, Graceway Pharmaceuticals, LLC, Coley Pharmaceutical Group, Inc.. Active years: 1995-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephen L Crooks. Retrieved from https://idiyas.com/inventor/stephen-l-crooks

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 40

% Patents Active = 60.0

Average Co-Inventor Count = 3.9

ph-index = 31

Forward Citations = 3,628(Granted Patents)


Location History:

  • Mathomedi, MN (US) (2004)
  • Saint Paul, MN (US) (2006)
  • Mahtomedi, MN (US) (1995 - 2010)

Company Filing History:

goldMedal37 out of 22,435 
 
3M Innovative Properties Company
 patents
silverMedal2 out of 7 
 
Graceway Pharmaceuticals, LLC
 patents
bronzeMedal1 out of 41 
 
Coley Pharmaceutical Group, Inc.
 patents
4. 1 out of 834,708 
Other
 patents
where one patent can have more than one assignee

Years Active: 1995-2010

Loading Chart...
Areas of Expertise:
Imidazoquinolines
Imidazonaphthyridines
Sulfonamide Substituted
Urea Substituted
Amido Ether
Chemical Intermediates
Medicinal Chemistry
Periodontal Disease Treatment
Sulfamide Substituted
Synthetic Processes
Pharmaceutical Compounds
Leukotriene Inhibition
40 patents (USPTO):Explore Patents
1. 7678918 - Intermediates for imidazonaphthyridines (2010-03-16),
2. 7393859 - Amide substituted imidazoquinolines (2008-07-01),
3. 7335773 - Intermediates for imidazonaphthyridines (2008-02-26),
4. 7157453 - Urea substituted imidazoquinolines (2007-01-02),
5. 7115622 - Amido ether substituted imidazoquinolines (2006-10-03),
6. 7078523 - Urea substituted imidazoquinoline ethers (2006-07-18),
7. 7049439 - Urea substituted imidazoquinoline ethers (2006-05-23),
8. 7038051 - Imidazonaphthyridines (2006-05-02),
9. 7030131 - Sulfonamide substituted imidazoquinolines (2006-04-18),
10. 6949646 - Imidazonaphthyridines (2005-09-27),
11. 6897221 - Urea substituted imidazoquinolines (2005-05-24),
12. 6894165 - Imidazonaphthyridines (2005-05-17),
13. 6888000 - Sulfonamide and sulfamide substituted imidazoquinolines (2005-05-03),
14. 6825350 - Sulfonamide and sulfamide substituted imidazoquinolines and methods for the treatment of periodontal disease using these and other immune response modifiers (2004-11-30),
15. 6800624 - Sulfonamide and sulfamide substituted imidazoquinolines (2004-10-05),

Title: The Innovative Journey of Stephen L Crooks

Introduction:

Stephen L Crooks, a talented inventor hailing from Mahtomedi, MN (US), has made significant contributions to the world of innovation with his creative mind and dedication to problem-solving.

Latest Patents:

Stephen L Crooks holds several patents in various fields, including technology, engineering, and consumer products. His latest patents showcase his versatility and forward-thinking approach to inventing.

Career Highlights:

Throughout his illustrious career, Stephen L Crooks has been recognized for his groundbreaking inventions that have improved efficiency and functionality in different industries. His passion for innovation has led to the development of cutting-edge solutions that have made a positive impact on society.

Collaborations:

Stephen L Crooks has collaborated with leading companies and research institutions to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many projects.

Conclusion:

In conclusion, Stephen L Crooks stands out as a visionary inventor who continues to push the boundaries of what is possible through his relentless pursuit of innovation. His contributions have left a lasting legacy in the world of inventions, inspiring future generations to think outside the box and create solutions that shape the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…